Middle East

Data indicates that people living in Middle Eastern countries tend to be either very happy or very unhappy.

Tony Cripps, CEO of SABB, discusses the benefits of the financial sector’s ongoing transformation.

Fragmented payment systems and a lack of standardization have hindered the cash management efforts of companies in the Middle East, but this looks set to change.

Before obtaining a new license, Standard Chartered tried several times to buy out a local lender.

Kuwait responded swiftly to the pandemic, but political feuds are slowing the reform agenda and increasing macroeconomic vulnerabilities.

The industry is a prime part of Qatar’s economic-diversification strategy.

Thanks to a successful vaccination campaign and higher energy prices, the country’s future looks bright. 

Questions abound about Najla Bouden’s ability to manage Tunisia's ongoing political crisis or the risk of bankruptcy raised by the country's central bank.

Africa’s third-biggest country gets ready for digital financial inclusion. 

Bahrain welcomes foreign direct investment as a solution to its needs.

Oil-rich nations continue to diversify their income streams away from fossil fuel-based enterprises.

Lebanon's richest man takes Lebanon's toughest job.

The ranks of the wealthy continue to grow in the GCC, and with their wealth growing in complexity, too, they are demanding ever more from their wealth managers.

In the aftermath of the pandemic and plummeting oil prices, GCC banks are looking to scale abroad, acquire new customers and grow globally.

Ahli United Bank CEO Adel El-Labban discusses business and Bahrain’s current economic challenges.

GCC countries are selling prime assets to fund economic transition.

Sunil Kaushal, Standard Chartered’s regional CEO for Africa and the Middle East, talks about upcoming changes for the bank and how it is faring coming out of the pandemic.

Abu Dhabi's IPO market is heating up.

Aiding clients in weathering the pandemic involves more than deploying a few service tweaks.

Gypto Pharma City will start by producing Covid-19-related medication and treatments for chronic illnesses such as diabetes, hypertension and heart disease.